SurvivorNet on MSN
A simpler delivery system: FDA approves subcutaneous injection version of powerful targeted drug isatuximab for multiple myeloma
A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
B-cell depletion is effective in MS and NMOSD, with anti-CD20 and anti-CD19 mAbs showing distinct mechanisms impacting safety and tolerability. Glycoengineering enhances ADCC activity, mitigating ...
Everyday Health on MSN
What is fixed-duration CLL treatment?
Fixed-duration CLL treatment is changing management options for the condition. Here’s what it is, how it works, its potential ...
Share on Pinterest New research suggests that a combination of two monoclonal antibodies can be an effective COVID-19 treatment. William Taufic/Getty Images A new study finds that a combination of two ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and structured analysis of 650+ ...
WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced it has initiated a discovery program for a measles monoclonal antibody (mAb). Multiple healthcare ...
A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox ...
Newborns and younger pediatric patients who have tested positive for COVID-19 can now receive monoclonal antibody treatments that were previously authorized for those 12 and older. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results